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Mesenchymal stromal/stem cells (MSCs) from human dental pulp (DP) can be expanded
in vitro for cell-based and regenerative dentistry therapeutic purposes. However, their
heterogeneity may be a hurdle to the achievement of reproducible and predictable
therapeutic outcomes. To get a better knowledge about this heterogeneity, we designed
a flow cytometric strategy to analyze the phenotype of DP cells in vivo and upon in
vitro expansion with stem cell markers. We focused on the CD31− cell population
to exclude endothelial and leukocytic cells. Results showed that the in vivo CD31−
DP cell population contained 1.4% of CD56+, 1.5% of CD146+, 2.4% of CD271+
and 6.3% of MSCA-1+ cells but very few Stro-1+ cells (≤1%). CD56+, CD146+,
CD271+, and MSCA-1+ cell subpopulations expressed various levels of these markers.
CD146+MSCA-1+, CD271+MSCA-1+, and CD146+CD271+ cells were the most
abundant DP-MSC populations. Analysis of DP-MSCs expanded in vitrowith a medicinal
manufacturing approach showed that CD146 was expressed by about 50% of CD56+,
CD271+, MSCA-1+, and Stro-1+ cells, and MSCA-1 by 15–30% of CD56+, CD146+,
CD271+, and Stro-1+ cells. These ratios remained stable with passages. CD271 and
Stro-1 were expressed by <1% of the expanded cell populations. Interestingly, the
percentage of CD56+ cells strongly increased from P1 (25%) to P4 (80%) both in all
sub-populations studied. CD146+CD56+, MSCA-1+CD56+, and CD146+MSCA-1+
cells were the most abundant DP-MSCs at the end of P4. These results established
that DP-MSCs constitute a heterogeneous mixture of cells in pulp tissue in vivo and in
culture, and that their phenotype is modified upon in vitro expansion. Further studies are
needed to determine whether co-expression of specific MSC markers confers DP cells
specific properties that could be used for the regeneration of human tissues, including
the dental pulp, with standardized cell-based medicinal products.
Keywords: human dental pulp, mesenchymal stromal cells, stem cell markers, CD56, CD146, immunophenotyping,
regenerative dentistry, cell-based medicinal products
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INTRODUCTION
Dental and craniofacial research currently explores a
variety of cell-based and tissue engineering protocols to
be used as alternatives to classical therapies that aimed at
repairing/regenerating damaged tissues (Ducret et al., 2015a;
Gorin et al., 2016). In particular, studies have demonstrated
that mesenchymal stromal/stem cells (MSCs) are suitable to
these protocols because of their high expansion ability and
differentiation potential both in culture and animal models.
MSC-based therapies have already been applied in the clinics
and mainly consist of administration of cells, alone, or together
with scaffolds, to damaged, or pathological sites (Pagella et al.,
2015). Bone marrow (BM), Wharton’s jelly and adipose tissue
are conventional sources of MSCs, but owing to the easy tooth
access and the low morbidity of tooth collection protocols,
dental pulp (DP) previously emerged as an valuable source of
MSCs for tissue engineering-based therapies (Huang et al., 2009;
Harrington et al., 2014). The DP is the loose connective tissue
located in the center of the tooth. Its main cellular components
are neural crest-derived mesenchymal cells that mostly reside
in the tissue in the form of undifferentiated mesenchymal
cells, fibroblasts, and highly differentiated dentin-forming
odontoblasts. Pioneering studies of Gronthos et al. (2000)
demonstrated that undifferentiated DP cells include a small
population—less than 5% of cells—that possess phenotypic
features of MSCs and are able to form a pulp-dentin complex
upon engraftment in vivo in immunodeficient mice (Gronthos
et al., 2000). DP-MSCs mostly reside in perivascular stem cell
niches that provide cells a highly regulated microenvironment
instructing them to remain quiescent and preventing them
to proliferate, differentiate, or undergo apoptosis (Moore and
Lemischka, 2006; Mitsiadis et al., 2007; Pagella et al., 2015).
Perivascular localization of DP-MSCs was ascertained by the fact
that a large proportion (more than 60%) of clonogenic DP-MSCs
were present in the pericyte fraction and by their expression
of specific pericyte and smooth muscle cell markers (Shi and
Gronthos, 2003; Alliot-Licht et al., 2005; Lopez-Cazaux et al.,
2006). Since then, several authors have reported the existence,
in the DP, of other MSC populations whose proliferation
and differentiation potentials are similar (Iohara et al., 2006;
Sonoyama et al., 2008; Huang et al., 2009; Kawashima, 2012;
Lv et al., 2014; Mayo et al., 2014). However, it remains unclear
if these populations also include sub-populations which may
differ in their self-renewal properties, lineage commitment, and
differentiation capabilities toward specific phenotypes such as
pulp fibroblasts and odontoblasts. This knowledge is however of
paramount importance since cell heterogeneity may be a hurdle
to the achievement of reproducible and predictable therapeutic
outcomes.
Although no definitive MSC markers have been identified so
far (Lv et al., 2014), DP-MSC populations have been characterized
mainly on the basis of the expression of cell surface molecules
including the bone marrow cell membrane antigen Stro-1
(Gronthos et al., 2000; Alliot-Licht et al., 2005), the melanoma
cell adhesion molecule MCAM/CD146 (a marker of perivascular
MSCs; Shi and Gronthos, 2003; Lv et al., 2014; Harkness
et al., 2016), the low affinity nerve growth factor receptor
p75NTR/CD271 (Waddington et al., 2009; Lv et al., 2014; Alvarez
et al., 2015; Tomlinson et al., 2016), the mesenchymal stem
cell antigen MSCA-1 (also known as TNAP/Tissue Non-Specific
Alkaline Phosphatase; Sobiesiak et al., 2010; Tomlinson et al.,
2015), and the neural cell adhesion molecule NCAM/CD56 (a
marker of neural and muscular MSC populations; Battula et al.,
2009; Sobiesiak et al., 2010; Bonnamain et al., 2013; Lv et al.,
2014). We recently isolated and easily amplified in culture a
population of MSCs from the DP of human developing third
molars with a medicinal manufacturing approach (Ducret et al.,
2015b). We showed by using flow cytometry that all cells of
this population expressed the mesenchymal cell markers CD10,
CD13, CD29, CD44, CD90, CD105, and CD166 in vitro, but
did not express the hematopoietic markers CD14, CD34, CD45,
CD79a, and HLA-DR or the endothelial cell/leucocyte marker
CD31 (Ducret et al., 2015a,b; Ducret et al., 2016). Stro-1 and
CD271 were expressed by a very low number (≤1%) of cultured
DP-MSCs, whereas CD146 andMSCA-1 were expressed by about
40 and 15% of DP-MSCs, respectively. These results suggested
that the DP-MSC population was heterogeneous andmay contain
several populations with different phenotypic and biological
properties. The objective of this study was to identify more
precisely the MSC populations present in the human DP in vivo
and the DP-MSC populations that can be isolated and expanded
up to four passages with our GMP approach. We analyzed with
flow cytometry the expression of CD56, CD146, CD271, MSCA-
1, and Stro-1 on CD31− DP cells to exclude endothelial and
leukocytic cells that may express some of the above markers
although being not MSCs.
MATERIALS AND METHODS
Isolation and Amplification of Human
Dental Pulp Cells
Healthy impacted human third molars were collected from
donors aged 13–17 years with informed consent of the patients
and their parents, in accordance with the recommendations of
the World Medical Association’s Declaration of Helsinki and
following a protocol approved by the French Ministry of Higher
Education and Research (CODECOH: DC-2014-2325). Dental
pulps from teeth between Nolla developmental stages 5 (crown
almost completed) and 7 (one third root completed) were gently
extirpated from pulp cavities and cut into fragments of about 0.5–
2mm3. For in vivo immunophenotyping analysis, pulp fragments
were digested in a mixture of 3 mg/mL collagenase type I
(Calbiochem, San Diego, CA, USA) and 4mg/mL dispase (Roche
Diagnostics, Meylan, France) at 37◦C for 1 h. The cell suspension
was then washed twice with sterile PBS, passed through a 100-µm
nylon mesh filter, and resuspended in phosphate buffered saline
(PBS). For in vitro immunophenotyping analysis, fragments were
treated as previously described (Ducret et al., 2015b). Briefly,
they were seeded as explants on dishes pre-coated with human
placental collagens I and III (ABCellBio, Paris, France), and
then cultured in the chemically defined culture medium SPE-
IV/EBM (ABCellBio) supplemented with 100 IU/mL penicillin
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and 100µg/mL streptomycin (Life Technologies, Saint Aubin,
France). DP-MSCs outgrowing from the explants were passaged
four times with the xeno-free recombinant protease TrypLe R©
Select 1X (Life Technologies) for amplification.
Multiparametric Flow Cytometry
The staining panel was designed by using 6 fluorochrome-
conjugated antibodies, and the nucleic acid dye 7AAD (7-Amino-
Actinomycin D, BD-Biosciences) was used for the exclusion
of non-viable cells (Table 1). Fluorescence Minus One (FMO)
controls were used in combination with isotype controls by
replacing the missing antibody in every FMO control tube with
the corresponding isotype control. This method enabled both the
visualization of staining issues (isotype control) as well as gating
boundaries (FMO control) without the need for multiple tubes,
thus saving time in sample preparation while requiring fewer
cells. Unstained controls were also used to check background-
and cell auto-fluorescence. Cell suspensions were prepared by
incubating 1.107 cells/mL in staining buffer containing 1% bovine
serum albumin (BD Pharmingen, Le Pont de Claix, France).
Hundred µL of cell suspension were then added to each of the
eight different antibodies combinations (Table 2) and incubation
was performed for 25min at 4◦C in the dark. Stained cells
were washed with BD Lyse Wash Assistant (BD Biosciences) to
maximize cell viability and prevent cell adhesion to the staining
tube. Samples were kept on ice and analyzed within 2 h of
processing after 10 min of incubation with 7-AAD. The gating
strategy was as follows: A primary gate was placed on the area
vs. height signal of the forward scatter (FSC-A/FSC-H) dot plot
to discriminate for doublets and clumps, and a Boolean gate
was then set on the 7-AADneg cells to enable the analysis of the
viable single cell population. CD31+ (endothelial and leukocytic)
cells were excluded from the analysis by setting a gate that
encompassed 99.9% of the events in the APC-Cy7 channel of
the FMO control tube 6 (Table 2 , Figure 1A). The single cell
population was identified by defining the gated population on a
side scatter area signal vs. a forward scatter area (SSC-A/FSC-
A) signal dot plot. The target number of acquired events for
each tube of the panel was 3.105 for in vitro and 5.104 for in
vivo immunophenotyping. This target was set to 1.105 events for
unstained, isotype-FMO and compensation controls. Data were
acquired as uncompensated events and recorded as FCS 3.0 files.
Analysis and compensation was performed using the FlowJo vX
software (TreeStar Inc., Ashland, OR, USA).
Statistical Analysis
Values were presented as the mean ± standard deviation, and
differences were analyzed using the Mann-Whitney U-test for
nonparametric analysis. The number of independent samples
from different donors (n) is indicated in figure legends. A P <
0.05 was signified with ∗ and P < 0.01 with ∗∗.
RESULTS
The human DP is well known to contain MSCs, but not sufficient
information is available regarding the immunophenotypic profile
of these cells. We therefore performed a flow cytometry analysis
of DP cells collected following enzymatic digestion of the whole
tissue. In this study, all in vivo and in vitro data were obtained
following the same gating strategy (Figure 1A): debris, non-
viable cells and doublets were first excluded, and then the analysis
was performed on the CD31− DP cell population. We found that
this population represented 98.4% of living cells in the whole DP
population and that it contained about 1.4% of CD56+ cells, 1.5%
of CD146+ cells, 2.4% of CD271+ cells, 6.3% of MSCA-1+, but
very few Stro-1+ cells (≤1%). In order to increase our knowledge
of DP cells expressing these MSC markers, we next gated the
CD56+, CD146+, CD271+, and MSCA-1+ cell populations and
analyzed the expression of these four markers. An example is
given in Figure 1B in the CD146+ cell population. Quantified
data for all gated cell populations are reported in Table 3. They
reveal that about 1.8, 4.6, and 6.4% of the CD56+ cell population
expressed CD146, CD271 and MSCA-1, respectively, whereas
2.6, 11.5, and 35.8% of the CD146+ cell population expressed
CD56, CD271, and MSCA-1, respectively. CD56 and Stro-1 were
found in 3.5%, CD146 in 9.1% and MSCA-1 in 18% of CD271+
cells. CD56 was expressed in 1.4% of MSCA-1+ cells, whereas
CD146 and CD271 were expressed by about 8 and 5.3% of the
MSCA-1+ population. Very few cells (<1%) expressed Stro-
1 in the gated CD56+, CD146+, and MSCA-1+ populations.
The multiplication of the percentage of DP cells expressing one
marker by the proportion of these cells expressing as second
marker indicated that, in decreasing order, CD146+MSCA-
1+, CD271+MSCA-1+, and CD146+CD271+ cells constitute
the most abundant MSC populations in the human DP, each
population representing between 0.1 and 0.5% of the total of
CD31− DP cells.
We previously showed that the whole DP-MSC population
expanded in vitro in serum-free medium with a GMP approach
did not express CD31, indicating that no endothelial or
leukocytic cells were present in our cultures. A high amount
of DP-MSCs was found to express CD146 (about 40%)
and MSCA-1 (15%), but CD271 and Stro-1 were expressed
by a very low number of cells (≤1%). These percentages
remained unchanged during the culture time analyzed, i.e.,
from passage 1 (P1) to passage 4 (P4) (Ducret et al.,
2015b). In the present study, we further observed that the
percentage of CD56+ DP-MSCs in the whole cultured DP-MSC
population, already high at P1 (about 25%), increased up to
P4 to reach 80% (Figure 2). The percentage of CD56+ cells
similarly increased in all the gated CD146+, CD271+, MSCA-
1+, and Stro-1+ DP-MSC populations (Figure 3). CD146 was
also expressed at high level, by about half the cells in the
CD56+, CD271+, MSCA-1+, and Stro-1+ populations. This
ratio remained stable with passages, except in the MSCA-1+
population in which CD146 expression increased significantly.
The percentage of cells expressing CD271 was very weak,
lower than 1%, in CD56+, CD146+, and MSCA-1+ cells, but
was higher (≈5%) in the Stro-1+ population. A significant
decrease of CD271 expressing cells was observed in the CD56+
and CD146+ populations. The percentage of cells expressing
MSCA-1 was around 15–30% in gated cell populations and
remained unchanged with passages. Finally, Stro-1 was expressed
by a very weak percentage of cells (lower than 2%) in
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TABLE 1 | Fluorochrome-conjugated monoclonal antibodies used for immunophenotypic analysis.
Target Fluorochrome Clone Manufacturer Reference Isotype Reference
CD31 APC-Cy7 WM59 Biolegend 303120 Mouse IgG1, k 400128
CD56 BV510 HCD56 Biolegend 318340 Mouse IgG1, k 562946
CD146 AF488 SHM-57 Biolegend 342008 Mouse IgG2a, k 400233
CD271 PE-Cy7 C40-1457 BD-Biosciences 562852 Mouse IgG1, k 557646
MSCA-1 APC W8B2 Biolegend 327308 Mouse IgG1, k 400120
Stro-1 PE IgM, l Santa Cruz sc-47733 PE Mouse IgM, l sc-2870
TABLE 2 | Fluorescence Minus One (FMO) control strategy.
FMO control tubes Panel
Tube 1 Tube 2 Tube 3 Tube 4 Tube 5 Tube 6 Tube 7
Isotype CD56 CD56 CD56 CD56 CD56 CD56 CD56
CD146 Isotype CD146 CD146 CD146 CD146 CD146 CD146
Stro-1 Stro-1 Isotype Stro-1 Stro-1 Stro-1 Stro-1 Stro-1
CD271 CD271 CD271 Isotype CD271 CD271 CD271 CD271
MSCA-1 MSCA-1 MSCA-1 MSCA-1 Isotype MSCA-1 MSCA-1 MSCA-1
CD31 CD31 CD31 CD31 CD31 Isotype CD31 CD31
7AAD 7AAD 7AAD 7AAD 7AAD 7AAD Empty 7AAD
CD56+, CD146+, CD271+, and MSCA-1+ populations, and
this percentage did not vary with the passages. Variations of
MSC markers between passages 1 (P1) and 4 (P4) in the
gated DP-MSC populations are summarized in Table 4. The
multiplication of the percentage of DP-MSCs by the proportion
of these cells expressing aseconds second marker indicated
that CD146+CD56+ (about 10% of the total cell number),
CD146+MSCA-1+ (≈6%), and MSCA-1+CD56+ (≈3%) cells
were the most abundant DP-MSC populations at the end of
P1 in our amplification conditions, whereas CD146+CD56+
(about 40%), MSCA-1+CD56+ (≈12%), and CD146+MSCA-1+
(≈8%) cells were the most abundant DP-MSC populations at the
end of P4.
DISCUSSION
Human dental pulp (DP) contains quiescent mesenchymal
stromal/stem cells (MSCs) which may be recruited from
perivascular areas to repair or regenerate, once activated, the
pulp/dentin tissue injured by dental caries, trauma or operative
procedures (Huang et al., 2009). Owing to their strong capacities
for proliferation and differentiation into DP specific cells such as
odontoblasts, DP-MSCs have been isolated and expanded in vitro
for cell-based and regenerative dentistry therapeutic purposes (La
Noce et al., 2014). However, cells amplified in vitro are highly
heterogeneous and comprise populations with different lineage
commitment related to their in vivo environment (Lv et al., 2014).
This heterogeneity is considered a hurdle to the achievement
of reproducible and predictable therapeutic outcomes (Ishizaka
et al., 2012). To gainmore insight intoDP-MSC heterogeneity, we
quantified the number of DP cells expressing the mesenchymal
stromal/stem cell markers CD56, CD146, CD271, MSCA-1, and
Stro-1. We focused our study on CD31− DP-MSCs to exclude
cells that may express some of these markers although being
not MSCs. Indeed, some endothelial cells are known to express
CD146 and Stro-1, and natural killer cells and some lymphocytes
may express CD56 (Shi and Gronthos, 2003;Woodfin et al., 2007;
Crisan et al., 2008; Ge et al., 2013; Lv et al., 2014; Harkness
et al., 2016; Melsen et al., 2016). Flow cytometry was recently
used to characterize the various populations of immune cells
present in the human DPwith a strategy of progressive cell gating
(Gaudin et al., 2015), and we designed in the present study a
similar strategy to allow for the identification and quantification
of DP-MSC subpopulations. We found that the CD31− DP cell
population, which represented more than 98% of the DP cells
isolated with our protocol, contained about 1.4% of CD56+ cells,
1.5% of CD146+ cells, 2.4% of CD271+ cells, 6.3% of MSCA-1+,
but very few Stro-1+ cells (<0.3%). CD146+ cells were previously
identified by immunohistochemistry in the human DP (Shi and
Gronthos, 2003; Alongi et al., 2010). More recently, Huang et al.
(2014) reported, by using flow cytometry, the presence of 2%
of CD146+ in the whole DP cell population. Our data indicate
that CD146+ cells represent about 1.5% of the CD31− DP cell
fraction. This lower amount may be explained by the fact that
we have excluded the CD31+CD146+ DP cells, which represent
DP endothelial cells (Nakashima et al., 2009). Conversely, the
percentage of CD271+ and MSCA-1+ cells was similar to that
reported in other studies (Waddington et al., 2009; Alvarez
et al., 2015; Tomlinson et al., 2015, 2016; Pan et al., 2016; Yasui
et al., 2016). We next investigated whether the various DP-
MSC subpopulations expressed another one of these markers.
Analysis of the CD31−CD146+ and CD31−CD271+ DP cell
populations indicated that they contain 35.8 and 18% of MSCA-
1+ cells, respectively, but only a low amount of Stro-1+ cells.
Frontiers in Physiology | www.frontiersin.org 4 November 2016 | Volume 7 | Article 512
Ducret et al. Immunophenotyping of Dental Pulp MSCs
FIGURE 1 | Immunophenotypic characterization of human dental pulp mesenchymal stromal cells in vivo. (A) Flow cytometry gating strategy used for the
removal of debris, doublets, dead cells and CD31+ cells. The CD31− cell population obtained after enzymatic digestion of the whole dental pulp represented 98.4%
of all recovered DP cells. It contained 1.38 ± 0.04% of CD56+ cells, 1.52 ± 0.40% of CD146+ cells, 2.39 ± 2.09% of CD271+ cells, 6.26 ± 2.62% of MSCA-1+,
but very few Stro-1+ cells (0.27 ± 0.05%). Mean values ± standard deviation obtained from 3 dental pulps from different patients. (B) Proportion of CD31− DP cells
stained with the CD146 antibody and percentages of CD56, CD271, MSCA-1, and Stro-1 positive cells in the CD146+ population. Data shown are from one
representative patient. n = 3.
The proportion of CD271+ cells positive for CD146 and Stro-1
was about 9.1 and 1.5%, respectively, a percentage much lower
than that recently reported in DPs from adult patients (Yasui
et al., 2016). Although both studies are not directly comparable
since these authors only considered CD90+CD271+ DP cells,
differences between their results and ours might also be related
to the age of the patients since the wisdom teeth we used
were from younger, 13–17 year-old patients. Co-expression of
CD146 and MSCA-1 was previously detected in perivascular
cells from adipose and muscular tissues where it was particularly
abundant in pericytes (Crisan et al., 2008). Since MSCA-1 was
shown to be mainly and strongly expressed in the subodontoblast
cell-rich zone in human teeth (Zweifler et al., 2014), it is
possible that the CD146+MSCA-1+ cell population we identified
in the human DP originated from pericytes localized in the
subodontoblast perivascular region (Alliot-Licht et al., 2005). To
our knowledge, we are the first to report the quantification of
CD56+ cells in the human DP by flow cytometry. CD56 was
previously localized by immunohistochemistry in the central
region of the mouse molar DP, but no indication was given on
the type of cells that expressed it (Obara and Takeda, 1993).
More recently, CD56 was immunolocalized in Schwann cells
surrounding perivascular nerve fibers in the DP of patients
who had undergone head and neck radiotherapy (Faria et al.,
2014). Since Schwann cells are able to generate MSCs then to
give rise to pulp cells and dentin-producing odontoblasts in
TABLE 3 | Percentage of cells expressing MSC surface markers in gated
DP cell populations (n = 3).
Gated DP Surface markers
cell population
CD56 CD146 CD271 MSCA-1 Stro-1
CD56+ − 1.78± 0.3 4.6± 1.5 6.4±2.9 0.7± 0.2
CD146+ 2.6±0.6 − 11.5± 3.9 35.8±3.3 0.4± 0.3
CD271+ 3.5±1.5 9.1± 5.3 − 18±10.5 1.5± 0.6
MSCA-1+ 1.4±0.3 8.0± 2.9 5.5± 2.8 − 0.6± 0.2
damaged adult mouse growing incisors (Kaukua et al., 2014),
it is possible that the CD56+ cells we identified in the healthy
human DP are part of the Schwann cell population, given the
capacity of our cultured CD56+ DP-MSCs to differentiate into
odontoblast-like cells upon specific induction (Ducret et al.,
2015b).
Besides the heterogeneity of the MSC population isolated
from the tissue, modification of cell immunophenotype during
amplification is an additional factor of MSC diversity in
vitro (Cournil-Henrionnet et al., 2008; Kozanoglu et al., 2009;
Bonnamain et al., 2013). We previously showed that the
proportion of CD146+, CD271+, MSCA-1+ and Stro-1+ cells
did not change in the whole DP-MSC population with passages
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FIGURE 2 | Quantification of CD56+ DP-MSCs upon in vitro
amplification. Proportion of cells expressing CD56 in the whole DP-MSC
population in vitro at the end of passages 1 (P1), 3 (P3), and 4 (P4). Error bars:
mean ± SD. n = 5. ** P < 0.01.
(Ducret et al., 2015b). We further demonstrate here that CD146
and MSCA-1 were co-expressed by the higher number of
cells in each gated DP-MSC population (about 50% and 15–
30%, respectively). A similar CD146+MSCA-1+ cell population,
isolated from the human skeletal muscle and non-muscle tissues,
was shown to easily differentiate into myogenic cells in culture
and in vivo (Crisan et al., 2008). CD146 is a transmembrane
glycoprotein which belongs to the immunoglobulin superfamily
of cell adhesion molecules. Its engagement leads to CD146
association with the actin cytoskeleton and regulation of cell
migration (Ouhtit et al., 2009). It is constitutively expressed
by endothelial cells, pericytes, smooth muscle cells, some
lymphocytes, and melanoma cells (Bardin et al., 2001). It is also
an early marker of MSCs of diverse origins, including bone
marrow, adipose tissue, umbilical cord and dental pulp (Wu
et al., 2016). CD146 is preferentially detected in MSCs with
high clonogenicity, multipotency and differentiation potential
(Lv et al., 2014). In human DP, CD146 was immunolocalized
in perivascular cell niches (Shi and Gronthos, 2003). We
previously showed that DP-MSCs expanded in our culture
conditions contain a high percentage (≈50%) of CD146-
expressing cells, suggesting that they may contain a high amount
of multipotent DP-MSCs. Their capacity to differentiate into
osteo/odontoblasts, adipocytes, and chondrocytes (Ducret et al.,
2015b; Fabre et al., in preparation) are in accordance with this
hypothesis.
One major finding of our work is the progressive increase in
the number of CD56-expressing DP-MSCs with passages in vitro.
CD56 (also called Neural Cell Adhesion Molecule or NCAM)
is a cell adhesion molecule which belongs to the superfamily of
immunoglobulin receptors. It is widely expressed in the central
nervous systems, in which it mediates several neuronal functions
by controlling intercellular adhesion, neurite outgrowth, and
cell migration, proliferation, survival and differentiation. These
events are triggered by the homophilic interaction of CD56
molecules on adjacent cells as well as by the heterophilic
binding of CD56 to other adhesion molecules, extracellular
matrix components or cell surface receptors (Hinsby et al., 2004;
Francavilla et al., 2007; Cavallaro and Dejana, 2011; Leshchyns’ka
and Sytnyk, 2016). CD56 is also expressed by muscle-derived
stem cells and natural killer cells and, interestingly, by cells
migrating from the cephalic neural crest (Kolkova et al., 2000;
Sinanan et al., 2004; Melsen et al., 2016). Upon in vitro expansion
of DP-MSCs in our serum-free culture conditions, the proportion
of CD56+ cells increased in the whole population, as well as
in gated CD146+, CD271+, MSCA-1+, and Stro-1+ cells, from
about 25% at the end of P1 to 80% at the end of P4. This
increase was very similar in all subpopulations, indicating that
it is not related to the expression of the other MSC markers
tested. High proportions of CD56+ cells have been previously
identified in cultures of human DP-MSCs, ranging from about
50–70% of the whole cell population (Degistirici et al., 2008;
Bonnamain et al., 2013; Tomlinson et al., 2015), but we are the
first to show the progressive increase in the number of CD56+
cells without the use of a neuro-inductive culture medium. This
increase might be related to the selection of a specific CD56+
cell population in DP explants by our culture conditions, in
relation to components present in the culture medium. Another
possibility is that CD56+ DP-MSCs migrating from the DP
explants possess high proliferative intrinsic capacities which
allow them for progressively overriding the CD56− DP-MSC
populations. Since DP mesenchymal cells are of neural crest
origin, several authors have suggested that cultures of DP-
MSCs expanded in vitro contained a high proportion of cells
of neural crest origin (Aurrekoetxea et al., 2015). Although a
direct link between neural crest-derived DP-MSCs and the neural
crest marker CD56 has not been established, it is reasonable
to speculate that our cultured CD56+ DP-MSC populations are
primarily composed of cells that possess greater capacities to
differentiate into cells of the neuronal lineage. This hypothesis
is strengthened by the fact that DP-MSCs share a common
origin with peripheral nerve glial progenitor cells (Kaukua
et al., 2014) and by the fact that the neural crest origin of
DP-MSCs confers them a greater capacity to differentiate into
neuronal cells than MSCs of mesodermal origin such as bone
marrow or adipose tissue MSCs (Arthur et al., 2008; Degistirici
et al., 2008; Huang et al., 2009; Alipour et al., 2010; Karaöz
et al., 2011; Bonnamain et al., 2013; Gervois et al., 2015).
CD56 was also related to myogenic stem cell differentiation
into myoblasts, chondrocytes and osteoblasts (Sinanan et al.,
2004; Crisan et al., 2008; Lecourt et al., 2010). The CD56+ cell
population within human muscle-derived cells was found to be
heterogeneous and composed of lineage-committed myogenic
cells and multipotent cells (Sinanan et al., 2004; Lecourt et al.,
2010). Similarly to our results, a few percents of freshly isolated
muscle stem cells expressed CD56, whereas more than 70%
expressed this marker after three passages (Lecourt et al.,
2010). In our study, increase in the percentage of CD56+
DP-MSCs with passages led to a modification of the relative
proportions of the cell populations in culture between P1 and
P4. Indeed, the most abundant DP-MSC populations were,
in decreasing order, CD146+CD56+, CD146+MSCA-1+, and
MSCA-1+CD56+ at the end of P1, whereas CD146+CD56+,
MSCA-1+CD56+, and MSCA-1+CD146+ cells were the most
abundant ones at the end of P4. MSCA-1+CD146+ were
recently identified in cultured DP-MSCs (Tomlinson et al.,
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FIGURE 3 | Immunophenotypic analysis of CD56+, CD146+, CD271+, MSCA-1+, and Stro-1+ DP-MSC populations upon in vitro amplification. MSC
markers’ expression in the gated populations during the amplification process. P < 0.05 was signified with * and <0.01 with **. n = 5.
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TABLE 4 | Variations of MSC markers between passages 1 (P1) and 4 (P4)
in the gated DP-MSC populations.
CD56 P1 P4 CD146+ population
CD271+ population
MSCA-1+ population
Stro-1+ population
CD146 P1 P4 MSCA-1+ population
CD271 P1 P4 CD56+ population
CD146+ population
, P < 0.05; P < 0.01.
2015), but their proportion was lower than that we found
(≈3 vs. ≈8% in our study), possibly owing to the presence
of serum in the culture medium of Tomlinson et al. (2015).
Co-expression of CD56 and MSCA-1 markers was previously
observed in DP-MSCs and bone marrow MSCs (Battula et al.,
2009; Sobiesiak et al., 2010; Tomlinson et al., 2015), and it
was associated with high clonogenicity and multipotency. Co-
expression of CD56 and CD146 has been described as a factor
promoting muscle cell differentiation (Lecourt et al., 2010; Bosch
et al., 2012). Finally, since CD56 and CD146 are both cell
adhesion molecules important for cell–cell contacts and cell
propagation, their co-expression in neighboring cells would
help recreate the appropriate environment of the stem niche
in vivo which allows them for retaining their stemness and
pluripotency.
In summary, the data reported in this study suggest that
DP-MSC populations in vivo possess diverse and complex
phenotypes. They also highlight the modifications of DP-MSC
fate that occur during in vitro expansion in serum-free medium,
leading to the progressive selection of possibly committed
populations. Further studies are needed to determine whether
co-expression of specific MSC markers confers DP cells specific
properties that could be used for the regeneration of human
tissues, including the dental pulp, with standardized cell-based
medicinal products.
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